CHIRON CORPORATION AMENDED AND RESTATED BYLAWS INDEXChiron Corp • March 5th, 2003 • Pharmaceutical preparations
AMENDMENTS TO GOVERNANCE AGREEMENT AND BYLAWSChiron Corp • March 5th, 2003 • Pharmaceutical preparations
WHEREAS, Sections 2.04 (b)(iv) and (vii) of that certain Governance Agreement dated as of November 20, 1994 between Chiron Corporation ("Chiron" or the "Company") and Novartis AG, requires the approval of a majority of the Investor Directors to amend the Bylaws of Chiron or to establish any committee of the Board of Directors of Chiron other than as provided in Section 2.03(b) (i) through (v) of the Governance Agreement;
AMENDMENT TO GOVERNANCE AGREEMENTGovernance Agreement • March 5th, 2003 • Chiron Corp • Pharmaceutical preparations
WHEREAS, Section 2.04 (a)(iv) of that certain Governance Agreement dated as of November 20, 1994 between Chiron Corporation ("Chiron" or the "Company") and Novartis AG, requires the approval of Novartis to change the size of the composition of any committee of the Board of Directors of Chiron;
